Selected gene polymorphisms and their interaction with maternal smoking, as risk factors for gastroschisis

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 76, Issue 10, 2006, Pages 723-730

  Torfs, Claudine P ^a,e   Christianson, Roberta E ^b   Iovannisci, David M ^c   Shaw, Gary M ^d   Lammer, Edward J ^c  

^a PUBLIC HEALTH INSTITUTE   (United States)

^b Child Health and Development Studies   (United States)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^d March of Dimes Birth Defects Foundation   (United States)

^e NONE   (United States)

Author keywords

Gastroschisis; Gene polymorphisms; Maternal smoking; Vascular hypothesis

Indexed keywords

ARGININE; ATRIAL NATRIURETIC FACTOR; DNA; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCINE; INTERCELLULAR ADHESION MOLECULE 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRYPTOPHAN;

ALLELE; ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; GASTROSCHISIS; GENOTYPE ENVIRONMENT INTERACTION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MATERNAL SMOKING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SUPERIOR MESENTERIC ARTERY; UMBILICAL VEIN; WOUND HEALING;

FEMALE; FOLLOW-UP STUDIES; GASTROSCHISIS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT, NEWBORN; MALE; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; MOTHERS; POLYMORPHISM, GENETIC; PREGNANCY; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 33750488462     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20310     Document Type: Article

References (48)

1. Aicher A, Heeschen C, Mildner-Rihm C, et al. 2003. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9:1370-1376.
2. Barsoom MJ, Prabulos A, Rodis JF, et al. 2000. Vanishing gastroschisis and short-bowel syndrome. Obstet Gynecol 96:818-819.
3. Botto LD, Khoury MJ. 2001. Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond. Am J Epidemiol 53:1016-1020.
4. Brown KS, Kluijtmans LA, Young IS, et al. 2004. The 5,10- methylenetetrahydrofolate reductase C677T polymorphism interacts with smoking to increase homocysteine. Atherosclerosis 174:315-322.
5. Bugge M, Hauge M. 1983. Gastroschisis og omphalocele i Danmark. En epidemiologisk undersogelse. Ugeskr Laeger 145:1323-1327. [Danish]
6. Campbell WB. 1993. Lipid-derived autacoids: eicosanoids and platelet-activating factor. In: Gilman AG, Rall TW, Nies AS, Taylor P, editors. Goodman and Gilman: the pharmacological basis of therapeutics. 8th ed. New York: McGraw-Hill. pp. 600-617.
7. Celayir S, Besik C, Sarimurat N, et al. 1999. Prenatally detected gastroschisis presenting as jejunal atresia due to vanishing bowel. Pediatr Surg Int 15:582-583.
8. Cheng S, Grow MA, Pallaud C, et al. 1999. A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res 9:936-949.
9. Chorostowska-Wynimko J, Skrzypczak-Jankun E, Jankun J. 2004. Plasminogen activator inhibitor type -1 controls the process of the in vitro sprout formation. J Physiol Pharmacol 55(Suppl 3):49-56.
10. Der Kaloustian VM, Hoyme HE, Hogg H, et al. 1991. Possible common pathogenetic mechanism for Poland sequence and Adams-Oliver syndrome. Am J Med Genet 38:69-73.
11. deVries PA. 1980. The pathogenesis of gastroschisis and omphalocele. J Pediatr Surg 15:245-251.
12. Emanuel I, Sever LE. 1973. Questions concerning the possible association of potatoes and neutral-tube defects, and an alternative hypothesis relating to maternal growth and development. Teratology 8:325-331.
13. Festa A, D'Agostino RD, Rich SS, et al. 2003. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites. Circulation 107:2422-2433.
14. Futagami A, Ishizaki M, Fukuda Y, et al. 2002. Wound healing involves induction of cyclooxygenase-2 expression in rat skin. Lab Invest 82:1503-1513.
15. Gaetani E, Flex A, Pola R, et al. 2002. The K469E polymorphism of the ICAM-1 gene is a risk factor for peripheral arterial occlusive disease. Blood Coagul Fibrinolysis 13:483-488.
16. Goldbaum G, Daling J, Milham S. 1990. Risk factors for gastroschisis. Teratology 42:397-403.
17. Guo X, Cheng S, Taylor KD, et al. 2005. Hypertension genes are genetic markers for insulin sensitivity and resistance. Hypertension 45:799-803.
18. Hovland DN Jr, Machado AF, Scott WJ Jr, et al. 1999. Differential sensitivity of the SWV and C57BL/6 mouse strains to the teratogenic action of single administrations of cadmium given throughout the period of anterior neuropore closure. Teratology 60:13-21.
19. Hoyme HE, Higginbottom MC, Jones KL. 1981. The vascular pathogenesis of gastroschisis: Intrauterine interruption of the omphalomesenteric artery. J Pediatr 98:228-231.
20. Hoyme HE, Jones MC, Jones KL. 1983. Gastroschisis: abdominal wall disruption secondary to early gestational interruption of the omphalome-senteric artery. Semin Perinatol 7:294-298.
21. Hummler E, Beermann F. 2000. Scnn1 sodium channel gene family in genetically engineered mice. J Am Soc Nephrol 11:5129-5134.
22. Iovannisci DM. 2000. Highly efficient recovery of DNA from dried blood using the MasterPur™ complete DNA and RNA purification kit. Epicenter Forum 7:6-8.
23. Jeong EM, Moon CH, Kim CS, et al. 2004. Cadmium stimulates the expression of ICAM-1 via NF-kappaB activation in cerebrovascular endothelial cells. Biochem Biophys Res Commun 320:887-892.
24. Kim SF, Huri DA, Snyder SH. 2005. Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science 310:1966-1970.
25. Kimble RM, Blakelock R, Cass D. 1999. Vanishing gut in infants with gastroschisis. Pediatr Surg Int 15:483-485.
26. Lam PK, Torfs CP. 2006. Interaction between maternal smoking and malnutrition in infant risk of gastroschisis. Birth Defects Res A Clin Mol Teratol 76:182-186.
27. Laulederkind SJF, Thompson-Jaeger S, Goorha S, et al. 2002. Both constitutive prostaglandin H synthase affect dermal wound healing in mice. Lab Invest 82:919-927.
28. Layne-MD, Yet SF, Maemura K, et al. 2001. Impaired abdominal wall development and deficient wound healing in mice lacking aortic carboxypeptidase-like protein. Mol Cell Biol 21:5256-5261.
29. Lembo G, De Luca N, Battagli C, et al. 2001. A common variant of endothelial nitric oxide synthase (Glu298Asp) is an independent risk factor for carotid atherosclerosis. Stroke 32:735-740.
30. Lewis GP, Coughlin LL, Jusko WJ, et al. 1972. Contribution of cigarette smoking to cadmium accumulation in man. Lancet 1:291-292.
31. McMurray CT, Tainer JA. 2003. Cancer, cadmium and genome integrity. Nat Genet 34:239-241.
32. Nauck M, Wieland H, Marz W. 1999. Rapid homogeneous genotyping of the 4G/5G polymorphism in promoter region of the PAI1 gene by Fluorescence resonance energy transfer and probe melting curves. Clin Chem 45:1141-1147.
33. Nelson TC, Toyama WM. 1995. Familial gastroschisis: a case of mother and son occurrence. J Pediatr Surg 30:1706-1708.
34. Ponthieux A, Lambert D, Herbeth B, et al. 2003. Association between Gly241Arg ICAM-1 gene polymorphism and serum sICAM-1 concentration in the Stanislas cohort. Eur J Hum Genet 11:679-686.
35. Reece A, Thornton J, Stringer MD. 1997. Genetic factors in the aetiology of gastroschisis: a case report. Eur J Obstet Gynecol Reprod Biol 73:127-128.
36. Robertson WL, Glinski LP, Kirkpatrick SJ, et al. 1992. Further evidence that arthrogryposis multiplex congenita in the human sometimes is caused by an intrauterine vascular accident. Teratology 45:345-351.
37. Shaw GM, Schaffer D, Velie EM, et al. 1995. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 6:219-226.
38. Singh J. 2003. Gastroschisis is caused by the combination of carbon monoxide and protein-zinc deficiency in mice. Birth Defects Res B Dev Reprod Toxicol 68:355-362.
39. Tawil A, Comstock CH, Chang CH. 2001. Prenatal closure of abdominal defect in gastroschisis: case report and review of the literature. Pediatr Dev Pathol 4:580-584.
40. Thompson J, Bannigan J. 2001. Effects of cadmium on formation of the ventral body wall in chick embryos and their prevention by zinc pretreatment. Teratology 64:87-97.
41. Torfs CP, Curry CJR. 1993. Familial cases of gastroschisis in a population-based registry. Am J Med Genet 45:465-467.
42. Torfs CP, Velie EM, Oechsli FW, et al. 1994. A population-based study of gastroschisis: demographic, pregnancy, and lifestyle risk factors. Teratology 50:44-53.
43. Torfs CP, Katz EA, Bateson TF, et al. 1996. Maternal medications and environmental exposures as risk factors for gastroschisis. Teratology 54:84-92.
44. Torfs CP, Lam PK, Schaffer DM, et al. 1998. Association between mothers' nutrient intake and their offspring's risk of gastroschisis. Teratology 58:241-250.
45. Vergouwen MD, Frijns CJ, Roos YB, et al. 2004. Plasminogen activator inhibitor-1 4G allele in the 4G/5G promoter polymorphism increases the occurrence of cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke 35:280-283.
46. Wenzel K, Ernst M, Rohde K, et al. 1996. DNA polymorphisms in adhesion molecule genes-a new risk factor for early atherosclerosis. Hum Genet 97:15-20.
47. Werler MM, Mitchell AA, Shapiro S. 1992. Demographic, reproductive, medical, and environmental factors in relation to gastroschisis. Teratology 45:353-360.
48. Werler MM, Sheehan JE, Mitchell AA. 2003. Association of vasoconstrictive exposures with risks of gastroschisis and small intestinal atresias. Epidemiology 14:349-354